BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18850018)

  • 21. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
    Loren AW; Bunin GR; Boudreau C; Champlin RE; Cnaan A; Horowitz MM; Loberiza FR; Porter DL
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):758-69. PubMed ID: 16785065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of MHC II-restricted minor histocompatibility antigens after HLA-identical stem-cell transplantation.
    Milosevic S; Bachnick B; Karim K; Bornkamm GW; Witter K; Gerbitz A; Mautner J; Behrends U
    Transplantation; 2010 Nov; 90(9):1030-5. PubMed ID: 20802400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH; Koldehoff M; Landt O; Beelen DW
    Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of unrelated donors for hematopoietic cell transplantation.
    Field T; Anasetti C
    Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family segregation analysis of inheritance of human minor histocompatibility antigen.
    Nishimura M; Mitsunaga S; Uchikawa C; Takahashi K; Tokunaga K; Tadokoro K; Juji T
    Cell Immunol; 1995 Jul; 163(2):319-22. PubMed ID: 7606803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
    Madrigal A; Shaw BE
    Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.
    Mo XD; Xu LP; Liu DH; Chen YH; Han W; Zhang XH; Chen H; Wang Y; Wang JZ; Liu KY; Huang XJ
    Bone Marrow Transplant; 2012 Sep; 47(9):1201-5. PubMed ID: 22231459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
    Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
    Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of minor histocompatibility antigens in solid organ transplantation.
    Dierselhuis M; Goulmy E
    Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequencies of 10 autosomal minor histocompatibility antigens in Korean population and estimated disparities in unrelated hematopoietic stem cell transplantation.
    Jung H; Ki CS; Kim JW; Kang ES
    Tissue Antigens; 2012 Jan; 79(1):42-9. PubMed ID: 22150369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
    Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
    Sellami MH; Torjemane L; Arias AE; Kaabi H; Ladeb S; Poli F; Othmane TB; Hmida S
    Clinics (Sao Paulo); 2010; 65(11):1099-103. PubMed ID: 21243279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
    Olsen KS; Jadi O; Dexheimer S; Bortone DS; Vensko SP; Bennett S; Tang H; Diiorio M; Saran T; Dingfelder D; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Weimer E; Hahn T; Sucheston-Campbell L; Armistead PM; Vincent BG
    Blood Adv; 2023 May; 7(9):1635-1649. PubMed ID: 36477467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
    Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Ambruzova Z; Mrazek F; Raida L; Jindra P; Vidan-Jeras B; Faber E; Pretnar J; Indrak K; Petrek M
    Bone Marrow Transplant; 2009 Aug; 44(4):227-35. PubMed ID: 19234509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Frequency of minor histocompatibility antigens among Chilean blood donors].
    Pérez N C; Rabanales T R; Larrondo L M; Alfaro L J
    Rev Med Chil; 2012 May; 140(5):555-60. PubMed ID: 23096659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.